Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  COVID-19

  Free Subscription


Articles published in Int J Infect Dis

Retrieve available abstracts of 451 articles:
HTML format



Single Articles


    November 2020
  1. JANAPALA RN, Patel J, Belfaqeeh O, Alhashmi A, et al
    Novaferon, Treatment in COVID-19 Patients.
    Int J Infect Dis. 2020 Nov 25. pii: S1201-9712(20)32493.
    PubMed    


  2. ZHENG F, Zhou Y, Zhou Z, Ye F, et al
    Reply to "Novaferon, Treatment in COVID-19 Patients".
    Int J Infect Dis. 2020 Nov 25. pii: S1201-9712(20)32492.
    PubMed    


  3. CASSAR MR, Borg D, Camilleri L, Schembri A, et al
    A novel use of telemedicine during the COVID-19 pandemic.
    Int J Infect Dis. 2020 Nov 24. pii: S1201-9712(20)32481.
    PubMed     Abstract available


  4. FERREIRA CE, Bonvehi PE, de la Torre JCG, Saenz-Flor KV, et al
    Algorithms for testing COVID-19 focused on use of RT-PCR and high-affinity serological testing: A consensus statement from a panel of Latin American experts.
    Int J Infect Dis. 2020 Nov 21. pii: S1201-9712(20)32484.
    PubMed     Abstract available


  5. TSANKOV BK, Allaire JM, Irvine MA, Lopez AA, et al
    Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32475.
    PubMed     Abstract available


  6. FINDEISEN P, Stiegler H, Lopez-Calle E, Schneider T, et al
    Clinical Performance Evaluation of a SARS-CoV-2 Rapid Antibody Test for Determining Past Exposure to SARS-CoV-2.
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32474.
    PubMed     Abstract available


  7. HABICHT ME, Eppenberger PE, Ruhli F
    A critical assessment on proposed outbreaks of plague and other epidemic diseases in Ancient Egypt.
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32470.
    PubMed     Abstract available


  8. MILETO D, Foschi A, Mancon A, Merli S, et al
    A case of extremely prolonged viral shedding: could cell cultures be a diagnostic tool to drive the COVID-19 patients discharge?
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32472.
    PubMed     Abstract available


  9. HAUSDORFF WP, Flores J
    Low dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19.
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32482.
    PubMed     Abstract available


  10. VAN NGUYEN Q, Cao DA, Nghiem SH
    The Spread of COVID-19 and Policy Responses in Vietnam: An Overview.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32466.
    PubMed     Abstract available


  11. ILIC I, Zdravkovic M, Timcic S, Stojanovic DU, et al
    Pneumonia in medical professionals during COVID-19 outbreak in cardiovascular hospital.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32465.
    PubMed     Abstract available


  12. NGIAM JN, Chew N, Tham SM, Beh DL, et al
    Demographic shift in COVID-19 patients in Singapore from an aged, at-risk population to young, migrant workers with reduced risk of severe disease.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32467.
    PubMed     Abstract available


  13. ALCOBA-FLOREZ J, Gil-Campesino H, Garcia-Martinez de Artola D, Diez-Gil O, et al
    Increasing SARS-CoV-2 RT-qPCR testing capacity by sample pooling.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32468.
    PubMed     Abstract available


  14. BALKHAIR A, Al-Zakwani I, Al Busaidi M, Al-Khirbash A, et al
    Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: results of a prospective, open-label, interventional study.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32458.
    PubMed     Abstract available


  15. FEDERGRUEN A, Naha S
    Crowding Effects Dominate Demographic Attributes in COVID-19 Cases.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32267.
    PubMed     Abstract available


  16. RABERAHONA M, Rakotomalala R, Rakotomijoro E, Rahaingoalidera T, et al
    Clinical and epidemiological features discriminating confirmed COVID-19 patients from SARS-CoV-2 negative patients at screening centres in Madagascar.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32462.
    PubMed     Abstract available


  17. DAIA C, Scheau C, Neagu G, Andone I, et al
    Nerve conduction study and electromyography findings in patients recovering from Covid-19 - case report.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32455.
    PubMed     Abstract available


  18. PATRIQUIN G, LeBlanc JJ
    SARS-CoV-2 sensitivity limbo - how low can we go?
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32446.
    PubMed    


  19. GORNY AW, Bagdasarian N, Koh Hong Kiat A, Lim YC, et al
    SARS-CoV-2 in Migrant Worker Dormitories: Geospatial Epidemiology Supporting Outbreak Management.
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32457.
    PubMed     Abstract available


  20. UDWADIA ZF, Singh P, Barkate H, Patil S, et al
    Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial.
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32453.
    PubMed     Abstract available


  21. TIWARI A, So MKP, Chong ACY, Chan JNL, et al
    Pandemic Risk of COVID-19 Outbreak in the United States: An Analysis of Network Connectedness with Air Travel Data.
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32454.
    PubMed     Abstract available


  22. KUMAR G, Adams A, Hererra M, Rojas ER, et al
    Predictors and Outcomes of HAIs in COVID-19 Patients.
    Int J Infect Dis. 2020 Nov 15. pii: S1201-9712(20)32447.
    PubMed     Abstract available


  23. ZOU H, Lu J, Liu J, Wong JH, et al
    Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis.
    Int J Infect Dis. 2020 Nov 14. pii: S1201-9712(20)32460.
    PubMed     Abstract available


  24. GIANDHARI J, Pillay S, Wilkinson E, Tegally H, et al
    Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report.
    Int J Infect Dis. 2020 Nov 12. pii: S1201-9712(20)32322.
    PubMed     Abstract available


  25. LI P, Wang Y, Peppelenbosch MP, Ma Z, et al
    Systematically comparing COVID-19 with 2009 influenza pandemic for hospitalized patients.
    Int J Infect Dis. 2020 Nov 12. pii: S1201-9712(20)32321.
    PubMed     Abstract available


  26. PATTERSON BK, Seethamraju H, Dhody K, Corley MJ, et al
    CCR5 Inhibition in Critical COVID-19 Patients Decreases Inflammatory Cytokines, Increases CD8 T-Cells, and Decreases SARS-CoV2 RNA in Plasma by Day 14.
    Int J Infect Dis. 2020 Nov 10. pii: S1201-9712(20)32305.
    PubMed     Abstract available


  27. RODRIGUEZ-NAVA G, Yanez-Bello MA, Trelles-Garcia DP, Chung CW, et al
    Performance of the Quick COVID-19 Severity Index and the Brescia-COVID Respiratory Severity Scale in hospitalized patients with COVID-19 in a community hospital setting.
    Int J Infect Dis. 2020 Nov 9. pii: S1201-9712(20)32314.
    PubMed     Abstract available


  28. XIAO J, Hu J, He G, Liu T, et al
    The time-varying transmission dynamics of COVID-19 and synchronous actions in China.
    Int J Infect Dis. 2020 Nov 9. pii: S1201-9712(20)32316.
    PubMed     Abstract available


  29. JAIN A, Rophina M, Mahajan S, Krishnan BB, et al
    Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays.
    Int J Infect Dis. 2020 Nov 9. pii: S1201-9712(20)32290.
    PubMed     Abstract available


  30. KHAMIS F, Al Naabi H, Al Lawati A, Ambusaidi Z, et al
    Randomized Controlled Open Label Trial on the Use of Favipiravir Combined with Inhaled Interferon beta-1b in Hospitalized Patients with Moderate to Severe COVID-19 Pneumonia.
    Int J Infect Dis. 2020 Nov 9. pii: S1201-9712(20)32319.
    PubMed     Abstract available


  31. TSO FY, Lidenge SJ, Pena PB, Clegg AA, et al
    High prevalence of pre-existing serological cross-reactivity against SARS-CoV-2 in sub-Sahara Africa.
    Int J Infect Dis. 2020 Nov 8. pii: S1201-9712(20)32310.
    PubMed     Abstract available


  32. JANG S, Rhee JY, Wi YM, Jung BK, et al
    Viral Kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period.
    Int J Infect Dis. 2020 Nov 4. pii: S1201-9712(20)32302.
    PubMed     Abstract available


  33. GRIMES JM, Khan S, Badeaux M, Rao RM, et al
    Arginine Depletion as a Therapeutic Approach for Patients with COVID-19.
    Int J Infect Dis. 2020 Nov 4. pii: S1201-9712(20)32304.
    PubMed     Abstract available


  34. SHI F, Wei Y, Xia L, Shan F, et al
    Lung volume reduction and infection localization revealed in big data CT imaging of COVID-19.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32300.
    PubMed     Abstract available


  35. VIMERCATI L, De Maria L, Quarato M, Caputi A, et al
    COVID-19 hospital outbreaks: Protecting healthcare workers to protect frail patients. An Italian observational cohort study.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32298.
    PubMed     Abstract available


  36. LOPEZ JH, Romo AS, Molina DC, Hernandez GA, et al
    DETECTION OF SARS-CoV-2 IN AIR OF TWO HOSPITAL IN HERMOSILLO, SONORA, MEXICO, UTILIZING A LOW-COST ENVIRONMENTAL MONITORING SYSTEM.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32293.
    PubMed     Abstract available


  37. TAKAHASHI W, Yoneda T, Koba H, Ueda T, et al
    Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32297.
    PubMed     Abstract available


  38. AL-QAHTANI M, AlAli S, Abdul Rahman AK, Salman Alsayyad A, et al
    The prevalence of asymptomatic and symptomatic COVID19 disease in a cohort of quarantined subjects.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32294.
    PubMed     Abstract available


  39. JAISWAL V, Nasa P, Raouf M, Gupta M, et al
    Therapeutic Plasma Exchange followed by Convalescent Plasma transfusion in critical COVID-19- an exploratory study.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32289.
    PubMed     Abstract available


  40. IPPOLITO G, Lauria FN, Locatelli F, Magrini N, et al
    Lessons from the COVID-19 Pandemic - Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe's Public Health Systems.
    Int J Infect Dis. 2020 Nov 2. pii: S1201-9712(20)32303.
    PubMed    


    October 2020
  41. TEHRANI S, Killander A, Astrand P, Jakobsson J, et al
    Risk factors for mortality in adult COVID-19 patients; frailty predicts fatal outcome in older patients.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32276.
    PubMed     Abstract available


  42. FU H, Wang H, Xi X, Boonyasiri A, et al
    A database for the epidemic trends and control measures during the first wave of COVID-19 in mainland China.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32279.
    PubMed     Abstract available


  43. ERDEM H, Lucey DR
    Health Care Worker Infections and Deaths due to COVID-9: A Survey from 37 Nations and a Call for WHO to Post National Data on their Website.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32268.
    PubMed    


  44. JOSHI S, Parkar J, Ansari A, Vora A, et al
    Role of favipiravir in the treatment of COVID-19.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32273.
    PubMed     Abstract available


  45. PIRALLA A, Ricchi M, Cusi MG, Prati P, et al
    Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19: is prolonged quarantine always justified?
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32278.
    PubMed     Abstract available


  46. JAEGER LH, Nascimento TC, Rocha FD, Vilela FMP, et al
    Adjusting RT-qPCR conditions to avoid unspecific amplification in SARS-CoV-2 diagnostic.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32283.
    PubMed     Abstract available


  47. BROUQUI P, Amrane S, Million M, Cortaredona S, et al
    Asymptomatic hypoxia in COVID-19 is associated with poor outcome.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32271.
    PubMed     Abstract available


  48. OLIVIERI A, Palu G, Sebastiani G
    Covid-19 cumulative incidence, intensive care and mortality in Italian regions compared to selected European countries.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32277.
    PubMed     Abstract available


  49. NALUMANSI A, Lutalo T, Kayiwa J, Watera C, et al
    Field Evaluation of the Performance of a SARS-CoV-2 Antigen Rapid Diagnostic Test in Uganda using Nasopharyngeal Samples.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32275.
    PubMed     Abstract available


  50. DANIELE F, Albert F
    The art of the possible in approaching efficacy trials for COVID19 convalescent plasma.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32274.
    PubMed     Abstract available


  51. EBRAHIM SH, Gozzer E, Ahmed Y, Imtiaz R, et al
    COVID19 in the Least Developed Fragile and Conflict-Affected Countries - How Can the Most Vulnerable be Protected?
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32259.
    PubMed     Abstract available


  52. CELIK HG, Keske S, Sener U, Tekbas M, et al
    Why we should be more careful using hydroxychloroquine in influenza season?
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32284.
    PubMed     Abstract available


  53. XIAO D, Li X, Su X, Mu D, et al
    Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?
    Int J Infect Dis. 2020 Oct 28. pii: S1201-9712(20)32263.
    PubMed     Abstract available


  54. BO Y, Guo C, Lin C, Zeng Y, et al
    Effectiveness of non-pharmaceutical interventions on COVID-19 transmission in 190 countries from 23 January to 13 April 2020.
    Int J Infect Dis. 2020 Oct 28. pii: S1201-9712(20)32270.
    PubMed     Abstract available


  55. PASSARELLI VC, Faico-Filho K, Moreira LVL, Cunha AP, et al
    Asymptomatic COVID-19 in hospital visitors: underestimated potential of viral shedding.
    Int J Infect Dis. 2020 Oct 28. pii: S1201-9712(20)32261.
    PubMed     Abstract available


  56. RAOULT D
    How useful is serology for COVID-19?
    Int J Infect Dis. 2020 Oct 28. pii: S1201-9712(20)32262.
    PubMed    


  57. CHOI MJ, Kang M, Shin SY, Noh JY, et al
    Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32266.
    PubMed     Abstract available


  58. YASSINE HM, Al-Jighefee H, Al-Sadeq DW, Dargham SR, et al
    Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32246.
    PubMed     Abstract available


  59. ESPINDOLA OM, Brandao CO, Gomes YCP, Siqueira M, et al
    Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32247.
    PubMed     Abstract available


  60. HIRAYAMA A, Masui J, Murayama A, Fujita S, et al
    The characteristics and clinical course of patients with COVID-19 who received invasive mechanical ventilation in Osaka, Japan.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32255.
    PubMed     Abstract available


  61. LOEVINSOHN G, Hardick J, Sinywimaanzi P, Fenstermacher KZJ, et al
    Respiratory pathogen diversity and co-infections in rural Zambia.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32258.
    PubMed     Abstract available


  62. CABELLO A, Zamarro B, Nistal S, Victor V, et al
    COVID-19 DISEASE IN PEOPLE LIVING WITH HIV: A MULTICENTER CASE-SERIES STUDY.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32264.
    PubMed     Abstract available


  63. GODIN A, Xia Y, Buckeridge DL, Mishra S, et al
    The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada - a mathematical modeling study of surveillance data.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32251.
    PubMed     Abstract available


  64. HERNANDEZ-MORA MG, Cabello Ubeda A, Perez LP, Alvarez FV, et al
    Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32249.
    PubMed     Abstract available


  65. FREIRE-PASPUEL B, Garcia-Bereguiain MA
    Analytical sensitivity and clinical performance of a triplex RT-qPCR assay using CDC N1, N2 and RP targets for SARS-CoV-2 diagnosis.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32250.
    PubMed     Abstract available


  66. MASYENI S, Santoso MS, Widyaningsih PD, Wedha Asmara DG, et al
    Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32248.
    PubMed     Abstract available


  67. BURREL S, Hausfater P, Dres M, Pourcher V, et al
    Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32244.
    PubMed     Abstract available


  68. CHEN CWS, Lee S, Dong MC, Taniguchi M, et al
    What Factors Drive the Satisfaction of Citizens on Governments' Responses to COVID-19?
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32254.
    PubMed     Abstract available


  69. SHAROV KS
    HIV/SARS-CoV-2 co-infection: T cell profile, cytokine dynamics and role of exhausted lymphocytes.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32253.
    PubMed     Abstract available


  70. VELAVAN TP, Meyer CG
    Reply to: Asymptomatic infection by SARS 2 coronavirus: invisible but invincible.
    Int J Infect Dis. 2020 Oct 17. pii: S1201-9712(20)32238.
    PubMed    


  71. VENUGOPAL U, Jilani N, Rabah S, Shariff MA, et al
    SARS-CoV-2 Seroprevalence Among Health Care Workers in a New York City Hospital: A Cross-Sectional Analysis During the COVID-19 Pandemic.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32240.
    PubMed     Abstract available


  72. HERZBERG J, Vollmer T, Fischer B, Becher H, et al
    A Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32230.
    PubMed     Abstract available


  73. LAWAL Y
    Africa's low COVID-19 mortality rate: A paradox?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32242.
    PubMed     Abstract available


  74. ABAYOMI A, Odukoya O, Osibogun A, Wright O, et al
    Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32228.
    PubMed     Abstract available


  75. NAKAMOTO T, Ishikane M, Sasaki R, Ohmagari N, et al
    Periungual desquamation in a Japanese Adult recovering from severe COVID-19.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32233.
    PubMed     Abstract available


  76. MOHAMMAD A, Alshawaf E, Marafie SK, Abu-Farha M, et al
    Higher binding affinity of Furin to SARS-CoV-2 spike (S) protein D614G could be associated with higher SARS-CoV-2 infectivity.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32237.
    PubMed     Abstract available


  77. BAECK M, Herman A
    COVID toes: where do we stand with the current evidence?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32225.
    PubMed     Abstract available


  78. DAUBY N, Bottieau E
    The unfinished story of hydroxychloroquine in COVID-19: the right anti-inflammatory dose at the right moment?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32236.
    PubMed    


  79. STAADEGAARD L, Taylor RJ, Spreeuwenberg P, Caini S, et al
    Monitoring the mortality impact of COVID-19 in Europe: What can be learned from 2009 influenza H1N1p mortality studies?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32241.
    PubMed     Abstract available


  80. NG CFS, Seposo XT, Moi ML, Tajudin MABA, et al
    Characteristics of COVID-19 epidemic and control measures to curb transmission in Malaysia.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32231.
    PubMed     Abstract available


  81. MOHANA A, Sulaiman T, Mahmoud N, Hassanein M, et al
    Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32235.
    PubMed     Abstract available


  82. MADSEN LW, Lindvig SO, Rasmussen LD, Knudtzen FC, et al
    Low mortality of hospitalised patients with COVID-19 in a tertiary Danish hospital setting.
    Int J Infect Dis. 2020 Oct 12. pii: S1201-9712(20)32221.
    PubMed     Abstract available


  83. LAI CC, Wang JH, Hsueh PR
    Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32214.
    PubMed     Abstract available


  84. ZHOU F, You C, Zhang X, Qian K, et al
    Epidemiological Characteristics and Factors Associated with Critical Time Intervals of COVID-19 in Eighteen Provinces, China: A Retrospective Study.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32220.
    PubMed     Abstract available


  85. PIETSCH H, Escher F, Aleshcheva G, Baumeier C, et al
    Proof of SARS-CoV-2 Genomes in Endomyocardial Biopsy with Latency After Acute Infection.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32215.
    PubMed     Abstract available


  86. KIMURA T, Namkoong H
    Susceptibility of obese population to COVID-19.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32218.
    PubMed     Abstract available


  87. KLAUSNER Z, Fattal E, Hirsch E, Shapira SC, et al
    A single holiday was the turning point of the COVID-19 policy of Israel.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32219.
    PubMed     Abstract available


  88. ZHANG K, Vilches TN, Tariq M, Galvani AP, et al
    The impact of mask-wearing and shelter-in-place on COVID-19 outbreaks in the United States.
    Int J Infect Dis. 2020 Oct 8. pii: S1201-9712(20)32204.
    PubMed     Abstract available


  89. COTA G, Freire ML, de Souza CS, Pedras MJ, et al
    Diagnostic performance of commercially available COVID-19 serology tests in Brazil.
    Int J Infect Dis. 2020 Oct 8. pii: S1201-9712(20)32211.
    PubMed     Abstract available


  90. NAGANT C, Ponthieux F, Smet J, Dauby N, et al
    A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer.
    Int J Infect Dis. 2020 Oct 8. pii: S1201-9712(20)32206.
    PubMed     Abstract available


  91. AL MASKARI Z, Al Blushi A, Khamis F, Al Tai A, et al
    Characteristic of Healthcare Workers Infected with COVID-19, a Cross-Sectional Observational Study.
    Int J Infect Dis. 2020 Oct 8. pii: S1201-9712(20)32212.
    PubMed     Abstract available


  92. GAUTRET P, Colson P, Lagier JC, Camoin-Jau L, et al
    Different pattern of the second outbreak of COVID-19 in Marseille, France.
    Int J Infect Dis. 2020 Oct 7. pii: S1201-9712(20)32208.
    PubMed     Abstract available


  93. SHIM E, Tariq A, Chowell G
    Spatial variability in reproduction number and doubling time across two waves of the COVID-19 pandemic in South Korea, February to July 2020.
    Int J Infect Dis. 2020 Oct 7. pii: S1201-9712(20)32210.
    PubMed     Abstract available


  94. SIMULUNDU E, Mupeta F, Chanda-Kapata P, Saasa N, et al
    First COVID-19 Case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.
    Int J Infect Dis. 2020 Oct 6. pii: S1201-9712(20)32196.
    PubMed     Abstract available


  95. JIAN SW, Cheng HY, Huang XT, Liu DP, et al
    Contact tracing with digital assistance in Taiwan's COVID-19 outbreak response.
    Int J Infect Dis. 2020 Oct 6. pii: S1201-9712(20)32200.
    PubMed     Abstract available


  96. RUBIO-RIVAS M, Ronda M, Padulles A, Mitjavila F, et al
    Beneficial Effect of Corticosteroids in Preventing Mortality in Patients Receiving Tocilizumab to Treat Severe COVID-19 Illness.
    Int J Infect Dis. 2020 Oct 6. pii: S1201-9712(20)32202.
    PubMed     Abstract available


  97. SHIRIN T, Bhuiyan TR, Charles RC, Amin S, et al
    Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh.
    Int J Infect Dis. 2020 Oct 5. pii: S1201-9712(20)32199.
    PubMed     Abstract available


  98. SUN M, Ruan X, Li Y, Wang P, et al
    Clinical characteristics of 30 COVID-19 patients with epilepsy: a retrospective study in Wuhan.
    Int J Infect Dis. 2020 Oct 2. pii: S1201-9712(20)32191.
    PubMed     Abstract available


  99. CALDERARO A, De Conto F, Buttrini M, Piccolo G, et al
    Human respiratory viruses, including SARS-CoV-2, circulating in the winter season 2019-2020 in Parma, Northern Italy.
    Int J Infect Dis. 2020 Oct 2. pii: S1201-9712(20)32189.
    PubMed     Abstract available


  100. DE SIMONE G, Mancusi C
    Finding the right time for anti-inflammatory therapy in COVID-19.
    Int J Infect Dis. 2020 Oct 1. pii: S1201-9712(20)32170.
    PubMed    


  101. NEWALL AT, Leong RNF, Nazareno A, Muscatello DJ, et al
    Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: evolution in the estimated risk of mortality throughout the epidemic.
    Int J Infect Dis. 2020 Oct 1. pii: S1201-9712(20)32194.
    PubMed     Abstract available


  102. TAO J, Gao H, Zhu S, Yang L, et al
    Influenza versus COVID-19 cases among influenza-illness-like patients in travelers from Wuhan to Hong Kong in January 2020.
    Int J Infect Dis. 2020 Oct 1. pii: S1201-9712(20)32190.
    PubMed     Abstract available


  103. MALVIYA A
    The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.
    Int J Infect Dis. 2020;99:310-311.
    PubMed    


    September 2020
  104. LUCA P, Cassandro C, Ralli M, Gioacchini FM, et al
    Sudden sensorineural hearing loss and COVID-19: (commentary about "Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss" from Osman Kilic,
    Int J Infect Dis. 2020 Sep 30. pii: S1201-9712(20)32183.
    PubMed    


  105. MUSA HH, Musa TH, Musa IH, Musa IH, et al
    Addressing Africa's pandemic puzzle: perspectives on COVID-19 infection and mortality in sub-Saharan Africa.
    Int J Infect Dis. 2020 Sep 30. pii: S1201-9712(20)32172.
    PubMed     Abstract available


  106. BAGHAKI S, Yalcin CE, Baghaki HS, Aydin SY, et al
    COX2 Inhibition in the Treatment of COVID-19: Review of Literature to Propose Celecoxib Repositioning for Randomized Controlled Studies.
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32182.
    PubMed     Abstract available


  107. LAMMERS AJJ, Brohet RM, Theunissen REP, Koster C, et al
    Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients.
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32175.
    PubMed     Abstract available


  108. MAZHAR F, Hadi MA, Kow CS, Marran AMN, et al
    Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32186.
    PubMed     Abstract available


  109. MEYEROWITZ-KATZ G, Merone L
    A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates.
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32180.
    PubMed     Abstract available


  110. KALCIOGLU MT, Cag Y, Kilic O, Tuysuz O, et al
    May COVID-19 cause sudden sensorineural hearing loss?
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32184.
    PubMed    


  111. VASSALLO M, Manni S, Pini P, Blanchouin E, et al
    Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32154.
    PubMed     Abstract available


  112. BLAGOJEVIC NR, Bosnjakovic D, Vukomanovic V, Arsenovic S, et al
    Acute pericarditis and SARS-CoV-2: case report.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32156.
    PubMed     Abstract available


  113. FACCINI-MARTINEZ AA, Rivero R, Garay E, Garcia A, et al
    Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32167.
    PubMed     Abstract available


  114. BAGNATO S, Boccagni C, Marino G, Prestandrea C, et al
    Reply to "SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?"
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32178.
    PubMed    


  115. KAMINSKI MA, Sunny S, Balabayova K, Kaur A, et al
    Tocilizumab Therapy of COVID-19: A Comparison of Subcutaneous and Intravenous Therapies.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32164.
    PubMed     Abstract available


  116. FINSTERER J, Scorza FA
    SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32177.
    PubMed    


  117. SHAO S, Wang Y, Kang H, Tong Z, et al
    Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: a systematic review and meta-analysis.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32159.
    PubMed     Abstract available


  118. AGERGAARD CN, Lis-Tonder J, Olsen DA, Kierkegaard H, et al
    Challenging diagnostics in familial transmission from asymptomatic COVID-19 carrier. Should we group SARS-CoV-2 samples from households?
    Int J Infect Dis. 2020 Sep 26. pii: S1201-9712(20)32158.
    PubMed    


  119. TAKOI H, Togashi Y, Fujimori D, Kaizuka H, et al
    Favipiravir-induced fever in coronavirus disease 2019: A report of two cases.
    Int J Infect Dis. 2020 Sep 26. pii: S1201-9712(20)32166.
    PubMed     Abstract available


  120. KARAHASAN YAGCI A, Can Sarinoglu R, Bilgin H, Yanilmaz O, et al
    Relationship of the Cycle Threshold Values of SARS-CoV-2 Polymerase Chain Reaction and Total Severity Score of Computerized Tomography in Patients with COVID 19.
    Int J Infect Dis. 2020 Sep 26. pii: S1201-9712(20)32165.
    PubMed     Abstract available


  121. CHAABNA K, Doraiswamy S, Mamtani R, Cheema S, et al
    Facemask use in community settings to prevent respiratory infection transmission: a rapid review and meta-analysis.
    Int J Infect Dis. 2020 Sep 25. pii: S1201-9712(20)32150.
    PubMed     Abstract available


  122. ISERNIA V, Julia Z, Le Gac S, Bachelard A, et al
    SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital.
    Int J Infect Dis. 2020 Sep 25. pii: S1201-9712(20)32152.
    PubMed     Abstract available


  123. KHABA MC, Ngale TC, Madala N
    COVID-19 in an HIV-infected patient. Lessons learned from an autopsy case.
    Int J Infect Dis. 2020 Sep 25. pii: S1201-9712(20)32151.
    PubMed     Abstract available


  124. SKRIP L, Derra K, Kabore M, Noori N, et al
    Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis.
    Int J Infect Dis. 2020 Sep 25. pii: S1201-9712(20)32148.
    PubMed     Abstract available


  125. ABDULRAHMAN A, AlAli S, Yaghi O, Shabaan M, et al
    COVID-19 and Sickle Cell Disease in Bahrain.
    Int J Infect Dis. 2020 Sep 24. pii: S1201-9712(20)32149.
    PubMed     Abstract available


  126. WANNIGAMA DL, Jacquet A
    NOD2-dependent BCG-induced trained immunity: a way to regulate innate responses to SARS- CoV2?
    Int J Infect Dis. 2020 Sep 24. pii: S1201-9712(20)32145.
    PubMed     Abstract available


  127. MUKWENHA S, Dzinamarira T, Mugurungi O, Musuka G, et al
    Maintaining robust HIV and TB services in the COVID-19 era: A public health dilemma in Zimbabwe.
    Int J Infect Dis. 2020 Sep 23. pii: S1201-9712(20)32141.
    PubMed     Abstract available


  128. COLSON P, Esteves-Vieira V, Giraud-Gatineau A, Zandotti C, et al
    Temporal and age distributions of SARS-CoV-2 and other coronaviruses, Southeastern France.
    Int J Infect Dis. 2020 Sep 22. pii: S1201-9712(20)32133.
    PubMed     Abstract available


  129. PINNETTI C, Vergori A, Agrati C, Castilletti C, et al
    SARS-CoV-2 infection does not induce HIV viral escape in Central Nervous System: a case series.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30756.
    PubMed     Abstract available


  130. MORENO-PEREZ O, Leon-Ramirez JM, Fuertes-Kenneally L, Perdiguero M, et al
    Hypokalemia as a sensitive biomarker of disease severity and invasive mechanical ventilation requirement in COVID-19 pneumonia: a case series of 306 Mediterranean patients.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30749.
    PubMed     Abstract available


  131. D'ARMINIO MONFORTE A, Tavelli A, Bai F, Tomasoni D, et al
    The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease.
    Int J Infect Dis. 2020;100:67-74.
    PubMed     Abstract available


  132. SELTZER S
    Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30757.
    PubMed     Abstract available


  133. LV H, Zhang W, Zhu Z, Xiong Q, et al
    Prevalence and recovery time of olfactory and gustatory dysfunctions of hospitalized patients with COVID19 in Wuhan, China.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30755.
    PubMed     Abstract available


  134. BABIN S
    Use of Weather Variables in SARS-CoV-2 Transmission Studies.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30748.
    PubMed     Abstract available


  135. PICON RV, Carreno I, da Silva AA, Mossmann M, et al
    Coronavirus Disease 2019 Population-based Prevalence, Risk Factors, Hospitalization, and Fatality Rates in Southern Brazil.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30745.
    PubMed     Abstract available


  136. ALAJMI J, Jeremijenko AM, Abraham JC, Alishaq M, et al
    COVID-19 Infection Among Healthcare Workers in a National Healthcare System: the Qatar Experience.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30743.
    PubMed     Abstract available


  137. OWOLABI OA, Jallow AO, Jallow M, Sowe G, et al
    Delay in diagnosis of pulmonary tuberculosis in The Gambia, West Africa: a cross-sectional study.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30744.
    PubMed     Abstract available


  138. LETELLIER A, Gibelin A, Voiriot G, Fartoukh M, et al
    Destructive pulmonary fibrosis after severe COVID-19 pneumonia.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30741.
    PubMed    


  139. LEDNICKY JA, Lauzardo M, Hugh Fan Z, Jutla A, et al
    Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30739.
    PubMed     Abstract available


  140. NG MY, Wan EYF, Wong HYF, Leung ST, et al
    Development and Validation of Risk Prediction Models for COVID-19 Positivity in a Hospital Setting.
    Int J Infect Dis. 2020 Sep 15. pii: S1201-9712(20)30738.
    PubMed     Abstract available


  141. ZHANG A, Leng Y, Zhang Y, Wu K, et al
    Meta-Analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19.
    Int J Infect Dis. 2020 Sep 15. pii: S1201-9712(20)30737.
    PubMed     Abstract available


  142. ZHAO SZ, Wong JYH, Luk TT, Wai AKC, et al
    Mental health crisis under COVID-19 pandemic in Hong Kong, China.
    Int J Infect Dis. 2020 Sep 15. pii: S1201-9712(20)30746.
    PubMed     Abstract available


  143. VALENZUELA-RODRIGUEZ G, Zambrano LI, Munoz-Lara F, Pecho-Silva S, et al
    Intranational differences in the case fatality rates for COVID-19 among Peruvian physicians.
    Int J Infect Dis. 2020 Sep 13. pii: S1201-9712(20)30735.
    PubMed    


  144. AFRIN LB, Weinstock LB, Molderings GJ
    Covid-19 Hyperinflammation and Post-Covid-19 Illness May Be Rooted in Mast Cell Activation Syndrome.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30732.
    PubMed     Abstract available


  145. JOTHIMANI D, Kailasam E, Danielraj S, Nallathambi B, et al
    COVID-19: Poor outcomes in patients with Zinc deficiency.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30730.
    PubMed     Abstract available


  146. WEN J, Cheng Y, Ling R, Dai Y, et al
    Antibody-dependent enhancement of Coronavirus.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30731.
    PubMed     Abstract available


  147. SUARDI LR, Pallotto C, Esperti S, Tazzioli E, et al
    Risk factors for non-invasive/invasive-ventilatory support in patients with COVID-19 pneumonia: a retrospective study within a multidisciplinary approach.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30728.
    PubMed     Abstract available


  148. EGHTESSADI R, Mukandavire Z, Mutenherwa F, Cuadros D, et al
    Safeguarding gains in the Sexual and Reproductive Health and AIDS Response amidst COVID-19: The Role of African Civil Society.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30725.
    PubMed     Abstract available


  149. AZIZ AB, Raqib R, Khan WA, Rahman M, et al
    Integrated control of COVID-19 in resource poor countries.
    Int J Infect Dis. 2020 Sep 8. pii: S1201-9712(20)30724.
    PubMed     Abstract available


  150. YASUI Y, Yasui H, Suzuki K, Saitou T, et al
    Analysis of the predictive factors for critical illness of COVID-19 during treatment - Relationship between serum zinc level and critical illness of COVID-19.
    Int J Infect Dis. 2020 Sep 7. pii: S1201-9712(20)30723.
    PubMed    


  151. DUGAS M, Schrempf IM, Ochs K, Frommel C, et al
    Association of contact to small children with mild course of COVID-19.
    Int J Infect Dis. 2020 Sep 5. pii: S1201-9712(20)30720.
    PubMed     Abstract available


  152. SILVERIO A, Di Maio M, Ciccarelli M, Carrizzo A, et al
    Timing of national lockdown and mortality in COVID-19: the Italian experience.
    Int J Infect Dis. 2020 Sep 5. pii: S1201-9712(20)30722.
    PubMed     Abstract available


  153. STEIN RA, Young LM
    From ACE2 to COVID-19: A Multiorgan Endothelial Disease.
    Int J Infect Dis. 2020 Sep 4. pii: S1201-9712(20)30716.
    PubMed    


  154. NIKOLAI LA, Meyer CG, Kremsner PG, Velavan TP, et al
    Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible.
    Int J Infect Dis. 2020 Sep 3. pii: S1201-9712(20)30706.
    PubMed     Abstract available


  155. OZOG DM, Sexton JZ, Narla S, Pretto-Kernahan CD, et al
    The Effect of Ultraviolet C Radiation Against Different N95 Respirators Inoculated with SARS-CoV-2.
    Int J Infect Dis. 2020 Sep 3. pii: S1201-9712(20)30709.
    PubMed     Abstract available


  156. ABUHABIB AA, Abu-Aita SN, Procter C, Al-Smeri I, et al
    Unique situation of Gaza Strip dealing with COVID-19 crisis.
    Int J Infect Dis. 2020 Sep 3. pii: S1201-9712(20)30699.
    PubMed     Abstract available


  157. TRAN TA, Cezar R, Frandon J, Kabani S, et al
    CT scan does not make a diagnosis of Covid-19: a cautionary case report.
    Int J Infect Dis. 2020 Sep 2. pii: S1201-9712(20)30703.
    PubMed     Abstract available


    August 2020
  158. CORCHUELO J, Ulloa FC
    Oral manifestations in a patient with a history of asymptomatic COVID-19. Case Report.
    Int J Infect Dis. 2020 Aug 31. pii: S1201-9712(20)30700.
    PubMed     Abstract available


  159. ABOU GHAYDA R, Lee KH, Han YJ, Ryu S, et al
    Estimation of global case fatality rate of coronavirus disease 2019 (COVID-19) using meta-analyses: Comparison between calendar date and days since the outbreak of the first confirmed case.
    Int J Infect Dis. 2020 Aug 31. pii: S1201-9712(20)30694.
    PubMed     Abstract available


  160. BAI Y, Jiang D, Lon JR, Chen X, et al
    Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes reveal its epidemic trends.
    Int J Infect Dis. 2020 Aug 28. pii: S1201-9712(20)30695.
    PubMed     Abstract available


  161. SCIALPI M
    Pneumonia misinterpretation in COVID-19: revisitation and update.
    Int J Infect Dis. 2020 Aug 28. pii: S1201-9712(20)30696.
    PubMed    


  162. REGEN F, Eren N, Heuser I, Hellmann-Regen J, et al
    A Simple Approach to Optimum Pool Size for Pooled SARS-CoV-2 Testing.
    Int J Infect Dis. 2020 Aug 28. pii: S1201-9712(20)30692.
    PubMed     Abstract available


  163. MAHER B, Chavez R, Tomaz GCQ, Nguyen T, et al
    A fluid mechanics explanation of the effectiveness of common materials for respiratory masks.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30621.
    PubMed     Abstract available


  164. KIM YJ, Seo MH, Yeom HE
    Discussion on selecting the number of breaks in the pattern of spread of COVID-19 (a reply to Zhao and Liang).
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30693.
    PubMed    


  165. ZHAO S, Liang X
    A re-analysis to identify the structural breaks in the COVID-19 transmissibility during the early phase of the outbreak in South Korea.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30690.
    PubMed    


  166. COLEBUNDERS R, Siewe Fodjo JN, Vanham G, Van den Bergh R, et al
    A call for strengthened evidence on targeted, non-pharmaceutical interventions against COVID-19 for the protection of vulnerable individuals in sub-Saharan Africa.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30687.
    PubMed     Abstract available


  167. SADASIVAM B, Atal S, Ray A, Sharma S, et al
    The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30688.
    PubMed    


  168. TORRES JP, Izquierdo G, Acuna M, Pavez D, et al
    Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30691.
    PubMed     Abstract available


  169. HINOJOSA-VELASCO A, de Oca PVB, Garcia-Sosa LE, Mendoza-Duran JG, et al
    A Case Report of Newborn Infant with Severe COVID-19 in Mexico: Detection of SARS-CoV-2 in Human Breast Milk and Stool.
    Int J Infect Dis. 2020 Aug 26. pii: S1201-9712(20)30684.
    PubMed     Abstract available


  170. GUAN Q, Sadykov M, Mfarrej S, Hala S, et al
    A genetic barcode of SARS-CoV-2 for monitoring global distribution of different clades during the COVID-19 pandemic.
    Int J Infect Dis. 2020 Aug 22. pii: S1201-9712(20)30681.
    PubMed     Abstract available


  171. MARVISI M, Ferrozzi F, Balzarini L, Mancini C, et al
    First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: factors predicting fibrotic evolution.
    Int J Infect Dis. 2020 Aug 22. pii: S1201-9712(20)30683.
    PubMed     Abstract available


  172. ADAMSON PC, Goodman-Meza D, Vijayan T, Yang S, et al
    Diagnostic yield of repeat testing for SARS-CoV-2: Experience from a large health system in Los Angeles.
    Int J Infect Dis. 2020 Aug 21. pii: S1201-9712(20)30678.
    PubMed     Abstract available


  173. XU Y, Cheng M, Chen X, Zhu J, et al
    Current approach in laboratory testing for SARS-CoV-2.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30671.
    PubMed     Abstract available


  174. AL WAHAIBI A, Al Manji A, Al Maani A, Al Rawahi B, et al
    COVID-19 epidemic monitoring after non-pharmaceutical interventions: the use of time-varying reproduction number in a country with a large migrant population.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30668.
    PubMed     Abstract available


  175. LIU J, Zeng W, Cao Y, Cui Y, et al
    Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30674.
    PubMed     Abstract available


  176. BONILLA-ALDANA DK, Jimenez-Diaz SD, Arango-Duque JS, Aguirre-Florez M, et al
    Bats in Ecosystems and their Wide Spectrum of Viral Infectious Threats: SARS-CoV-2 and other emerging viruses.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30680.
    PubMed     Abstract available


  177. MACAULEY P, Martin A, Epelbaum O
    CORTICOSTEROIDS IN THE TREATMENT OF SEVERE COVID-19 LUNG DISEASE: THE PULMONOLOGY PERSPECTIVE FROM THE FIRST UNITED STATES EPICENTER.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30670.
    PubMed     Abstract available


  178. TAKAHASHI H, Iwasaki Y, Watanabe T, Ichinose N, et al
    Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30677.
    PubMed     Abstract available


  179. AHERFI S, Gautret P, Chaudet H, Raoult D, et al
    Clusters of COVID-19 associated with Purim celebration in the Jewish community in Marseille, France, March 2020.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30679.
    PubMed     Abstract available


  180. PETERSEN E, Zumla A
    Advancing COVID-19 vaccines - avoiding different regulatory standards for different vaccines and need for open and transparent data sharing.
    Int J Infect Dis. 2020 Aug 18. pii: S1201-9712(20)30675.
    PubMed    


  181. GENDROT M, Duflot I, Boxberger M, Delandre O, et al
    Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.
    Int J Infect Dis. 2020 Aug 14. pii: S1201-9712(20)30661.
    PubMed     Abstract available


  182. LU YF, Pan LY, Zhang WW, Cheng F, et al
    A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19.
    Int J Infect Dis. 2020 Aug 13. pii: S1201-9712(20)30652.
    PubMed     Abstract available


  183. OBOH MA, Omoleke SA, Ajibola O, Manneh J, et al
    Translation of genomic epidemiology of infectious pathogens: Enhancing African genomics hubs for outbreaks.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30656.
    PubMed     Abstract available


  184. KOH WC, Naing L, Wong J
    Estimating the impact of physical distancing measures in containing COVID-19: an empirical analysis.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30655.
    PubMed     Abstract available


  185. ORTOLAN A, Lorenzin M, Felicetti M, Doria A, et al
    Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30607.
    PubMed     Abstract available


  186. LIM JT, Dickens BL, Cook AR, Khoo AL, et al
    The Costs of an Expanded Screening Criteria for COVID-19: A Modelling Study.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30654.
    PubMed     Abstract available


  187. HIROTSU Y, Maejima M, Shibusawa M, Nagakubo Y, et al
    Comparison of Automated SARS-CoV-2 Antigen Test for COVID-19 Infection with Quantitative RT-PCR using 313 Nasopharyngeal Swabs Including from 7 Serially Followed Patients.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30658.
    PubMed     Abstract available


  188. KLOPFENSTEIN T, Zayet S, Lohse A, Selles P, et al
    Impact of Tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30653.
    PubMed     Abstract available


  189. IM JH, Je YS, Baek J, Chung MH, et al
    Nutritional status of patients with coronavirus disease 2019 (COVID-19).
    Int J Infect Dis. 2020 Aug 11. pii: S1201-9712(20)30647.
    PubMed     Abstract available


  190. ISRAELI O, Beth-Din A, Paran N, Stein D, et al
    Evaluating the efficacy of RT-qPCR SARS-CoV-2 direct approaches in comparison to RNA extraction.
    Int J Infect Dis. 2020 Aug 10. pii: S1201-9712(20)30644.
    PubMed     Abstract available


  191. LA HOZ-RESTREPO F, Alvis-Zakzuk NJ, la Hoz-Gomez JF, la Hoz-Gomez A, et al
    Is Colombia an example of successful containment of the COVID-19 2020 pandemic? A critical analysis of the epidemiological data. March to July 2020.
    Int J Infect Dis. 2020 Aug 10. pii: S1201-9712(20)30646.
    PubMed     Abstract available


  192. LIN CY, Wang WH, Urbina AN, Tseng SP, et al
    Corrigendum to "Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan" [Int J Infect Dis 97 (2020) 240-244].
    Int J Infect Dis. 2020;98:440.
    PubMed    


  193. DEL BRUTTO OH, Costa AF, Mera RM, Recalde BY, et al
    SARS-CoV-2-related mortality in a rural Latin American population.
    Int J Infect Dis. 2020 Aug 8. pii: S1201-9712(20)30630.
    PubMed     Abstract available


  194. ANDERSON M, Mossialos E
    Time to strengthen capacity in infectious disease control at the European level.
    Int J Infect Dis. 2020 Aug 8. pii: S1201-9712(20)30631.
    PubMed     Abstract available


  195. ZUMLA A, Azhar EI, Shafi S, Memish ZA, et al
    COVID-19 and the scaled-down 2020 Hajj Pilgrimage - Decisive, logical and prudent decision making by Saudi authorities overcomes pre-Hajj public health concerns.
    Int J Infect Dis. 2020 Aug 7. pii: S1201-9712(20)30643.
    PubMed    


  196. GUPTA R, Gant VA, Williams B, Enver T, et al
    Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30632.
    PubMed     Abstract available


  197. MUMOLI N, Vitale J, Mazzone A
    Clinical Immunity in Discharged Medical Patients with COVID 19.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30623.
    PubMed    


  198. LIN YC, Chen MY, Liu MC, Lin YJ, et al
    Quarantine Measures for Coronavirus Disease 2019 on a Cruise Ship, Taiwan, February 2020.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30641.
    PubMed     Abstract available


  199. GAO J, Hu X, Sun X, Luo X, et al
    Possible intrauterine infection: Positive nucleic acid testing results and consecutive positive SARS-CoV-2-specific antibody levels within 50 days after birth.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30608.
    PubMed     Abstract available


  200. MARTINCIC Z, Skopec B, Rener K, Mavric M, et al
    Severe immune thrombocytopenia in a critically ill COVID-19 patient.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30633.
    PubMed     Abstract available


  201. KLOPFENSTEIN T, Zahra H, Kadiane-Oussou NJ, Lepiller Q, et al
    New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30637.
    PubMed     Abstract available


  202. METTLER SK, Kim J, Maathuis MH
    Diagnostic serial interval as a novel indicator for contact tracing effectiveness exemplified with the SARS-CoV-2/COVID-19 outbreak in South Korea.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30611.
    PubMed     Abstract available


  203. CHUN JY, Baek G, Kim Y
    Transmission onset distribution of COVID-19.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30612.
    PubMed     Abstract available


  204. JUNG CY, Park H, Kim DW, Choi YJ, et al
    Clinical Characteristics of Asymptomatic Patients with COVID-19: A Nationwide Cohort Study in South Korea.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30634.
    PubMed     Abstract available


  205. ZUMLA A, Azhar EI, Alqahtani S, Shafi S, et al
    COVID-19 and the scaled-down 2020 Hajj Pilgrimage - Decisive, logical and prudent decision making by Saudi authorities overcomes pre-Hajj public health concerns.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30635.
    PubMed     Abstract available


  206. VARISCO TJ, Johnson ML, Thornton D
    Comment on Arshad et al: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30617.
    PubMed    


  207. LIU T, Gong D, Xiao J, Hu J, et al
    Cluster infections play important roles in the rapid evolution of COVID-19 transmission: a systematic review.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30619.
    PubMed     Abstract available


  208. POTERE N, Di Nisio M, Rizzo G, La Vella M, et al
    Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30616.
    PubMed     Abstract available


  209. BHAT P, Noval M, Doub JB, Heil E, et al
    COVID-19 and PCP co-infection in a severely immunocompromised 25 year-old patient.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30615.
    PubMed    


  210. WU J, Yu J, Zhou S, Zhang J, et al
    What can we learn from a COVID-19 lung biopsy?
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30610.
    PubMed     Abstract available


  211. BRITO-AZEVEDO A
    Hydroxychloroquine in COVID-19: taking care of statistic to take care of patients.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30614.
    PubMed    


  212. GODDEK S
    Vitamin D3 and K2 and their potential contribution to reducing the COVID-19 mortality rate.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30624.
    PubMed     Abstract available


  213. CAPONE A
    Simultaneous circulation of COVID-19 and flu in Italy: potential combined effects on the risk of death?
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30618.
    PubMed     Abstract available


  214. PRASETYO YT, Castillo AM, Salonga LJ, Sia JA, et al
    Factors Affecting Perceived Effectiveness of COVID-19 Prevention Measures among Filipino during Enhanced Community Quarantine in Luzon, Philippines: Integrating Protection Motivation Theory and Extended Theory of Planned Behavior.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30622.
    PubMed     Abstract available


  215. WISEMAN DM
    Re: Arshad S, Kilgore P, Chaudhry ZS et al. Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19. Int J Infect Dis: 2020. Epub 2020 Jul 1 http://doi.org/10.1016/j.ijid.2020.06.099.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30613.
    PubMed    


  216. LANGER-GOULD A, Smith JB, Gonzales EG, Castillo RD, et al
    Early Identification of COVID-19 Cytokine Storm and Treatment with Anakinra or Tocilizumab.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30609.
    PubMed     Abstract available


  217. VERHAGEN LM, de Groot R, Lawrence CA, Taljaard J, et al
    COVID-19 response in low- and middle-income countries: don't overlook the role of mobile phone communication.
    Int J Infect Dis. 2020 Aug 4. pii: S1201-9712(20)30625.
    PubMed     Abstract available


  218. UHM JS, Ahn JY, Hyun JH, Sohn Y, et al
    Patterns of Viral Clearance in the Natural Course of Asymptomatic Coronavirus Disease 2019 (COVID-19): Comparison with Symptomatic Nonsevere COVID-19.
    Int J Infect Dis. 2020 Aug 4. pii: S1201-9712(20)30620.
    PubMed     Abstract available


  219. BAGNATO S, Boccagni C, Marino G, Prestandrea C, et al
    Critical illness myopathy after COVID-19.
    Int J Infect Dis. 2020 Aug 4. pii: S1201-9712(20)30606.
    PubMed     Abstract available


  220. ZHAO D, Wang M, Wang M, Zhao Y, et al
    Asymptomatic infection by SARS-CoV-2 in healthcare workers: a study in a large teaching hospital in Wuhan, China.
    Int J Infect Dis. 2020 Aug 3. pii: S1201-9712(20)30627.
    PubMed     Abstract available


  221. ZHENG F, Zhou Y, Zhou Z, Ye F, et al
    SARS-CoV-2 Clearance in COVID-19 Patients with Novaferon Treatment: A Randomized, Open-label, Parallel Group Trial.
    Int J Infect Dis. 2020 Aug 3. pii: S1201-9712(20)30597.
    PubMed     Abstract available


  222. ZHANG W, Li L, Liu J, Chen L, et al
    The characteristics and predictive role of lymphocyte subsets in COVID-19 patients.
    Int J Infect Dis. 2020 Aug 3. pii: S1201-9712(20)30514.
    PubMed     Abstract available


  223. LU J, Wu D, Cao L, Ma X, et al
    Corrigendum to "Positive effects of COVID-19 control measures on pneumonia prevention" [Int J Infect Dis 96 (July) (2020) 548-549].
    Int J Infect Dis. 2020;97:404.
    PubMed    


    July 2020
  224. ZERVOS M, Arshad S, Kilgore P, Chaudhry ZS, et al
    A Sound Approach: Hydroxychloroquine Reduces Mortality in Severe COVID-19.
    Int J Infect Dis. 2020 Jul 31. pii: S1201-9712(20)30604.
    PubMed    


  225. IWATA K, Doi A, Miyakoshi C
    Was school closure effective in mitigating coronavirus disease 2019 (COVID-19)? Time series analysis using Bayesian inference.
    Int J Infect Dis. 2020 Jul 31. pii: S1201-9712(20)30598.
    PubMed     Abstract available


  226. ALCOBA-FLOREZ J, Gil-Campesino H, de Artola DG, Gonzalez-Montelongo R, et al
    Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection.
    Int J Infect Dis. 2020 Jul 31. pii: S1201-9712(20)30603.
    PubMed     Abstract available


  227. ATKINSON JG
    Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin and Combination in Patients Hospitalized with COVID-19".
    Int J Infect Dis. 2020 Jul 29. pii: S1201-9712(20)30602.
    PubMed    


  228. D'ARMINIO MONFORTE A, Tavelli A, Bai F, Marchetti G, et al
    Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation?
    Int J Infect Dis. 2020 Jul 29. pii: S1201-9712(20)30600.
    PubMed    


  229. ROSENBERG ES, Holtgrave DR, Udo T
    Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19.
    Int J Infect Dis. 2020 Jul 29. pii: S1201-9712(20)30599.
    PubMed    


  230. TAN L, Ma B, Lai X, Han L, et al
    Air and surface contamination by SARS-CoV-2 virus in a tertiary hospital in Wuhan, China.
    Int J Infect Dis. 2020 Jul 27. pii: S1201-9712(20)30571.
    PubMed     Abstract available


  231. KESKE S, Tekin S, Sait B, Irkoren P, et al
    Appropriate use of Tocilizumab in COVID-19 Infection.
    Int J Infect Dis. 2020 Jul 26. pii: S1201-9712(20)30580.
    PubMed     Abstract available


  232. NAKAGAWARA K, Masaki K, Uwamino Y, Kabata H, et al
    Acute Onset Olfactory/Taste Disorders are Associated with a High Viral Burden in Mild or Asymptomatic SARS-CoV-2 Infections.
    Int J Infect Dis. 2020 Jul 26. pii: S1201-9712(20)30578.
    PubMed     Abstract available


  233. KANEKURA T, Kawahara K
    Adsorptive granulocyte and monocyte apheresis: a potentially relevant therapeutic option for COVID-19.
    Int J Infect Dis. 2020 Jul 25. pii: S1201-9712(20)30569.
    PubMed     Abstract available


  234. ZHOU Y, Yang Q, Chi J, Dong B, et al
    Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis.
    Int J Infect Dis. 2020 Jul 25. pii: S1201-9712(20)30572.
    PubMed     Abstract available


  235. KOZLOVSKAYA L, Piniaeva A, Ignatyev G, Selivanov A, et al
    Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during COVID-19 outbreak.
    Int J Infect Dis. 2020 Jul 25. pii: S1201-9712(20)30566.
    PubMed     Abstract available


  236. SINHA P, Mostaghim A, Bielick CG, McLaughlin A, et al
    Early administration of Interleukin-6 inhibitors for patients with severe Covid-19 disease is associated with decreased intubation, reduced mortality, and increased discharge.
    Int J Infect Dis. 2020 Jul 25. pii: S1201-9712(20)30568.
    PubMed     Abstract available


  237. ABENZA-ABILDUA MJ, Novo-Aparicio S, Moreno-Zabaleta R, Algarra-Lucas MC, et al
    Encephalopathy in severe SARS-CoV2 infection: Inflammatory or infectious?
    Int J Infect Dis. 2020;98:398-400.
    PubMed     Abstract available


  238. LUETHGEN M, Eggeling J, Heyckendorf J, Lange C, et al
    Changes in taste and smell as an early marker for COVID-19.
    Int J Infect Dis. 2020 Jul 21. pii: S1201-9712(20)30562.
    PubMed    


  239. LEE JY, Hong SW, Hyun M, Park JS, et al
    Epidemiological and Clinical Characteristics of Coronavirus Disease 2019 in Daegu, South Korea.
    Int J Infect Dis. 2020 Jul 20. pii: S1201-9712(20)30561.
    PubMed     Abstract available


  240. DE SOUSA E, Ligeiro D, Lerias JR, Zhang C, et al
    Mortality in COVID-19 disease patients: Correlating Association of Major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants.
    Int J Infect Dis. 2020 Jul 18. pii: S1201-9712(20)30560.
    PubMed     Abstract available


  241. FUGLEBJERG NJU, Jensen TO, Hoyer N, Ryrso CK, et al
    Silent Hypoxia in Patients with SARS CoV-2 Infection before Hospital Discharge.
    Int J Infect Dis. 2020 Jul 11. pii: S1201-9712(20)30557.
    PubMed     Abstract available


  242. SUN M, Xu Y, He H, Zhang L, et al
    Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy.
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30542.
    PubMed     Abstract available


  243. SAIDAN MN, Shbool MA, Arabeyyat OS, T Al-Shihabi S, et al
    Estimation of the probable outbreak size of novel coronavirus (COVID-19) in social gathering events and industrial activities.
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30540.
    PubMed     Abstract available


  244. DIOSCORIDI L, Carrisi C
    Covid-19 exposure risk for family members of healthcare workers: an observational study.
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30541.
    PubMed     Abstract available


  245. DENG Z, Zhang M, Zhu T, Liu Z, et al
    Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19.
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30545.
    PubMed     Abstract available


  246. KIM S, Castro MC
    Spatiotemporal pattern of COVID-19 and government response in South Korea (as of May 31, 2020).
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30546.
    PubMed     Abstract available


  247. ALMOGY G
    Superspreaders and the spread pattern of COVID-19: Response to: "Do superspreaders generate new superspreaders? A hypothesis to explain the propagation pattern of COVID-19", International Journal of Infectious Diseases 96 (2020) 461-463.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30537.
    PubMed    


  248. AL-SADEQ DW, Nasrallah GK
    The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30533.
    PubMed     Abstract available


  249. ARSHAD S, Kilgore P, Chaudhry ZS, Jacobsen G, et al
    Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30534.
    PubMed     Abstract available


  250. YU X, Duan J, Jiang Y, Zhang H, et al
    Distinctive trajectories of COVID-19 epidemic by age and gender: a retrospective modeling of the epidemic in South Korea.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30536.
    PubMed     Abstract available


  251. LEE TC, MacKenzie LJ, McDonald EG, Tong SYC, et al
    An Observational Cohort Study of Hydroxychloroquine and Azithromycin for COVID-19: (Can't Get No) Satisfaction.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30530.
    PubMed     Abstract available


  252. TANG B, Xia F, Tang S, Bragazzi NL, et al
    The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemic in the final phase of the current outbreak in China.
    Int J Infect Dis. 2020;96:636-647.
    PubMed     Abstract available


  253. ZHANG H, Li HB, Lyu JR, Lei XM, et al
    Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection.
    Int J Infect Dis. 2020;96:19-24.
    PubMed     Abstract available


  254. ZHU W, Li X, Wu Y, Xu C, et al
    Community quarantine strategy against coronavirus disease 2019 in Anhui: An evaluation based on trauma center patients.
    Int J Infect Dis. 2020;96:417-421.
    PubMed     Abstract available


    June 2020
  255. DE NARDO P, Gentilotti E, Mazzaferri F, Cremonini E, et al
    Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30516.
    PubMed     Abstract available


  256. DUBERT M, Visseaux B, Isernia V, Bouadma L, et al
    Case reports study of the first five patients COVID-19 treated with remdesivir in France.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30528.
    PubMed     Abstract available


  257. ALKHAMIS MA, Youha SA, Khajah MM, Haider NB, et al
    Spatiotemporal Dynamics of COVID-19 epidemic in the State of Kuwait.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30512.
    PubMed     Abstract available


  258. CHEN X, Zhu B, Hong W, Zeng J, et al
    Associations of Clinical Characteristics and Treatment Regimens with Viral RNA Shedding Duration in Patients with COVID-19.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30526.
    PubMed     Abstract available


  259. NOH JY, Song JY, Yoon JG, Seong H, et al
    Safe Hospital Preparedness in the Era of COVID-19: The Swiss Cheese Model.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30529.
    PubMed     Abstract available


  260. SEIDU AA, Hagan JE Jr, Ameyaw EK, Ahinkorah BO, et al
    The role of testing in infectious disease control: A case of COVID-19 in Africa.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30525.
    PubMed     Abstract available


  261. LIANG Y, Xu J, Chu M, Mai J, et al
    Neurosensory dysfunction: a diagnostic marker of early COVID-19.
    Int J Infect Dis. 2020 Jun 29. pii: S1201-9712(20)30519.
    PubMed     Abstract available


  262. BAJUNIRWE F, Izudi J, Asiimwe S
    Long distance truck drivers and the increasing risk of COVID-19 spread in Uganda.
    Int J Infect Dis. 2020 Jun 29. pii: S1201-9712(20)30522.
    PubMed     Abstract available


  263. SHEN C, Yue X, Wang J, Shi C, et al
    Nocturnal oxygen therapy as an option for early COVID-19.
    Int J Infect Dis. 2020 Jun 26. pii: S1201-9712(20)30515.
    PubMed     Abstract available


  264. MANNUCCI E, Nreu B, Monami M
    Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy.
    Int J Infect Dis. 2020 Jun 26. pii: S1201-9712(20)30510.
    PubMed     Abstract available


  265. FUKUMOTO T, Iwasaki S, Fujisawa S, Hayasaka K, et al
    Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification.
    Int J Infect Dis. 2020 Jun 26. pii: S1201-9712(20)30509.
    PubMed     Abstract available


  266. HE D, Shi Z, Li Y, Cao P, et al
    Comparing COVID-19 and the 1918-19 influenza pandemics in United Kingdom.
    Int J Infect Dis. 2020 Jun 26. pii: S1201-9712(20)30511.
    PubMed     Abstract available


  267. AHMED MAM, Colebunders R, Siewe Fodjo JN
    Evidence for important COVID-19 community transmission in Somalia using a clinical case definition.
    Int J Infect Dis. 2020 Jun 25. pii: S1201-9712(20)30503.
    PubMed    


  268. ADAMU AA, Jalo RI, Habonimana D, Wiysonge CS, et al
    COVID-19 and routine childhood immunization in Africa: leveraging systems thinking and implementation science to improve immunization system performance.
    Int J Infect Dis. 2020 Jun 24. pii: S1201-9712(20)30507.
    PubMed     Abstract available


  269. BAVARO DF, Poliseno M, Scardapane A, Belati A, et al
    Occurrence of Acute Pulmonary Embolism in COVID-19 - A Case Series.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30501.
    PubMed    


  270. VELAVAN TP, Pollard AJ, Kremsner PG
    Herd Immunity and Vaccination of children for COVID19.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30500.
    PubMed    


  271. KHAMIS F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, et al
    Therapeutic Plasma Exchange in Adults with Severe COVID-19 Infection.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30499.
    PubMed     Abstract available


  272. GALVIN CJ, Li Jack YC, Malwade S, Syed-Abdul S, et al
    COVID-19 preventive measures showing an unintended decline in infectious diseases in Taiwan.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30496.
    PubMed     Abstract available


  273. AMZAT J, Aminu K, Kolo VI, Akinyele AA, et al
    Coronavirus Outbreak in Nigeria: Burden and Socio-Medical Response during the First 100 Days.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30502.
    PubMed     Abstract available


  274. TARIQ A, Mateen RM, Afzal MS, Saleem M, et al
    Paromomycin: a potential dual targeted drug effectively inhibits both Spike (S1) and Main Protease of COVID-19.
    Int J Infect Dis. 2020 Jun 21. pii: S1201-9712(20)30498.
    PubMed     Abstract available


  275. LAM HY, Lam TS, Wong CH, Lam WH, et al
    The Epidemiology of COVID-19 cases and the Successful Containment Strategy in Hong Kong - January to May 2020.
    Int J Infect Dis. 2020 Jun 21. pii: S1201-9712(20)30492.
    PubMed     Abstract available


  276. HE S, Zhou C, Lu D, Yang H, et al
    Relationship between Chest CT manifestations and immune response in COVID-19 patients.
    Int J Infect Dis. 2020 Jun 20. pii: S1201-9712(20)30494.
    PubMed     Abstract available


  277. POURGHASEMI HR, Pouyan S, Heidari B, Farajzadeh Z, et al
    Spatial modelling, risk mapping, change detection, and outbreak trend analysis of coronavirus (COVID-19) in Iran (days between 19 February to 14 June 2020).
    Int J Infect Dis. 2020 Jun 20. pii: S1201-9712(20)30493.
    PubMed     Abstract available


  278. SARTOR G, Riccio MD, Poz ID, Bonanni P, et al
    COVID-19 in Italy: considerations on official data.
    Int J Infect Dis. 2020 Jun 20. pii: S1201-9712(20)30495.
    PubMed     Abstract available


  279. AMIR M, Djaharuddin I, Sudharsono A, Ramadany S, et al
    COVID-19 Concomitant Infective Endocarditis: A-Case Report and Review of Management.
    Int J Infect Dis. 2020 Jun 20. pii: S1201-9712(20)30497.
    PubMed     Abstract available


  280. KIM YJ, Seo MH, Yeom HE
    Estimating a breakpoint in the spread pattern of COVID-19 in South Korea.
    Int J Infect Dis. 2020 Jun 19. pii: S1201-9712(20)30489.
    PubMed     Abstract available


  281. ALESSANDRA D, Lepore L, Palazzolo C, Barreca F, et al
    Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: mini-review of the literature.
    Int J Infect Dis. 2020 Jun 18. pii: S1201-9712(20)30491.
    PubMed     Abstract available


  282. EBRAHIM SH, Zhuo J, Gozzer E, Ahmed QA, et al
    All Hands on Deck: A Synchronized Whole-of-World Approach for COVID-19 Mitigation.
    Int J Infect Dis. 2020 Jun 18. pii: S1201-9712(20)30484.
    PubMed     Abstract available


  283. KRONBICHLER A, Kresse D, Yoon S, Lee KH, et al
    Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis.
    Int J Infect Dis. 2020 Jun 17. pii: S1201-9712(20)30487.
    PubMed     Abstract available


  284. LOBO AP, Cardoso-Dos-Santos AC, Rocha MS, Pinheiro RS, et al
    COVID-19 epidemic in Brazil: where we at?
    Int J Infect Dis. 2020 Jun 16. pii: S1201-9712(20)30479.
    PubMed     Abstract available


  285. TURCATO G, Panebianco L, Zaboli A, Scheurer C, et al
    Correlation between arterial blood gas test and CT volumetry in patients with SARS-CoV-2 in the emergency department.
    Int J Infect Dis. 2020 Jun 15. pii: S1201-9712(20)30468.
    PubMed    


  286. FILICE C, Poma GL, Above E, Dellafiore C, et al
    Is the fear of Covid-19 infection the same in all subjects?
    Int J Infect Dis. 2020 Jun 15. pii: S1201-9712(20)30475.
    PubMed    


  287. GUALLAR MP, Meirino R, Donat-Vargas C, Corral O, et al
    Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity.
    Int J Infect Dis. 2020 Jun 14. pii: S1201-9712(20)30470.
    PubMed     Abstract available


  288. EBINA-SHIBUYA R, Namkoong H, Shibuya Y, Horita N, et al
    Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases.
    Int J Infect Dis. 2020 Jun 14. pii: S1201-9712(20)30450.
    PubMed     Abstract available


  289. SATICI C, Demirkol MA, Altunok ES, Gursoy B, et al
    Performance of Pneumonia Severity Index and CURB-65 in Predicting 30-day mortality in patients with COVID-19.
    Int J Infect Dis. 2020 Jun 14. pii: S1201-9712(20)30473.
    PubMed     Abstract available


  290. ALI S, Pappachan JM, Mathew S
    Acute cor pulmonale from saddle pulmonary embolism in a patient with previous Covid-19 - should we prolong prophylactic anticoagulation?
    Int J Infect Dis. 2020 Jun 13. pii: S1201-9712(20)30474.
    PubMed     Abstract available


  291. LIU Z, Chu R, Gong L, Su B, et al
    The assessment of transmission efficiency and latent infection period on asymptomatic carriers of SARS-CoV-2 infection.
    Int J Infect Dis. 2020 Jun 13. pii: S1201-9712(20)30471.
    PubMed     Abstract available


  292. LIN CY, Wang WH, Urbina AN, Tseng SP, et al
    Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan.
    Int J Infect Dis. 2020 Jun 13. pii: S1201-9712(20)30466.
    PubMed     Abstract available


  293. RUTAYISIRE E, Nkundimana G, Mitonga HK, Boye A, et al
    What works and what does not work in response to COVID-19 prevention and control in Africa.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30460.
    PubMed     Abstract available


  294. PENARRUBIA AL, Ruiz M, Porco R, Rao SN, et al
    Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30463.
    PubMed     Abstract available


  295. LI Y, Wang H, Wang F, Du H, et al
    Comparison of Hospitalized Patients with pneumonia caused by COVID-19 and influenza A in children under 5 years.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30462.
    PubMed     Abstract available


  296. XIAO Y, Tang B, Wu J, Cheke RA, et al
    Linking key intervention timings to rapid decline of the COVID-19 effective reproductive number to quantify lessons from mainland China.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30449.
    PubMed     Abstract available


  297. SZMUDA T, Ali S, Hetzger TV, Rosvall P, et al
    Are Online Searches for the Novel Coronavirus (COVID-19) Related to Media or Epidemiology? A Cross-sectional Study.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30464.
    PubMed     Abstract available


  298. MIYAMAE Y, Hayashi T, Yonezawa H, Fujihara J, et al
    Duration of viral shedding in asymptomatic or mild cases of novel coronavirus disease 2019 (COVID-19) from a cruise ship: A single-hospital experience in Tokyo, Japan.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30456.
    PubMed     Abstract available


  299. KILIC O, Kalcioglu MT, Cag Y, Tuysuz O, et al
    Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30458.
    PubMed     Abstract available


  300. BOHNING D, Rocchetti I, Maruotti A, Holling H, et al
    Estimating the undetected infections in the Covid-19 outbreak by harnessing capture-recapture methods.
    Int J Infect Dis. 2020 Jun 10. pii: S1201-9712(20)30444.
    PubMed     Abstract available


  301. ZHOU Y, Zeng Y, Chen C
    Presence of SARS-CoV-2 RNA in Isolation Ward Environment 28 Days after Exposure.
    Int J Infect Dis. 2020 Jun 10. pii: S1201-9712(20)30451.
    PubMed    


  302. SANTOS JAD, Normando AGC, Silva RLCD, Paula RM, et al
    Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?
    Int J Infect Dis. 2020 Jun 8. pii: S1201-9712(20)30447.
    PubMed     Abstract available


  303. FINZI E
    Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients.
    Int J Infect Dis. 2020 Jun 6. pii: S1201-9712(20)30441.
    PubMed     Abstract available


  304. AZIZ H, Fatima S, Iqbal H, Faheem M, et al
    Recent Advances in Molecular diagnosis curbing the COVID-19.
    Int J Infect Dis. 2020 Jun 6. pii: S1201-9712(20)30439.
    PubMed    


  305. ESPINDOLA OM, Siqueira M, Soares CN, Lima MASD, et al
    Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.
    Int J Infect Dis. 2020 Jun 4. pii: S1201-9712(20)30431.
    PubMed     Abstract available


  306. LI H, Xu XL, Dai DW, Huang ZY, et al
    Air Pollution and temperature are associated with increased COVID-19 incidence: a time series study.
    Int J Infect Dis. 2020 Jun 2. pii: S1201-9712(20)30383.
    PubMed     Abstract available


  307. ZHANG L, Tao Y, Wang J, Ong JJ, et al
    Early characteristics of the COVID-19 outbreak predict the subsequent epidemic size.
    Int J Infect Dis. 2020 Jun 2. pii: S1201-9712(20)30429.
    PubMed     Abstract available


  308. LEE KCH, Sewa DW, Phua GC
    Potential role of statins in COVID-19.
    Int J Infect Dis. 2020 Jun 2. pii: S1201-9712(20)30422.
    PubMed     Abstract available


  309. MIZUMOTO K, Kagaya K, Chowell G
    Effect of the Wet Market on the coronavirus disease (COVID-19) transmission dynamics in China, 2019-2020.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30398.
    PubMed     Abstract available


  310. EDEAS M, Saleh J, Peyssonnaux C
    Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30417.
    PubMed     Abstract available


  311. MACINTYRE CR, Chughtai AA, Seale H, Dwyer DE, et al
    HUMAN CORONAVIRUS DATA FROM FOUR CLINICAL TRIALS OF MASKS AND RESPIRATORS.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30399.
    PubMed     Abstract available


  312. PORTE L, Legarraga P, Vollrath V, Aguilera X, et al
    Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30405.
    PubMed     Abstract available


  313. SHAH AUM, Safri SNA, Thevadas R, Noordin NK, et al
    COVID-19 Outbreak in Malaysia: Actions Taken by the Malaysian Government.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30400.
    PubMed     Abstract available


  314. MING DK, Sorawat S, Chanh HQ, Nhat PTH, et al
    Continuous physiological monitoring using wearable technology to inform individual management of infectious diseases, public health and outbreak responses.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30393.
    PubMed     Abstract available


  315. KENYON C
    The prominence of asymptomatic superspreaders in transmission mean universal face masking should be part of COVID-19 de-escalation strategies.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30409.
    PubMed    


  316. LUO S, Guo Y, Zhang X, Xu H, et al
    A Follow-up Study of Recovered Patients with COVID-19 in Wuhan, China.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30426.
    PubMed    


  317. PAPAMICHALIS P, Papadogoulas A, Katsiafylloudis P, Skoura AL, et al
    Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30425.
    PubMed     Abstract available


  318. BUONSENSO D, Cinicola B, Raffaelli F, Sollena P, et al
    Social consequences of COVID-19 in a low resource setting in Sierra Leone, West Africa.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30411.
    PubMed     Abstract available


  319. RUOCCO G, Feola M, Palazzuoli A
    Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity.
    Int J Infect Dis. 2020;95:373-375.
    PubMed     Abstract available


  320. WU D, Lu J, Liu Y, Zhang Z, et al
    Positive effects of COVID-19 control measures on influenza prevention.
    Int J Infect Dis. 2020;95:345-346.
    PubMed     Abstract available


    May 2020
  321. LI P, Chen L, Liu Z, Pan J, et al
    Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19.
    Int J Infect Dis. 2020 May 31. pii: S1201-9712(20)30415.
    PubMed     Abstract available


  322. ITAYA T, Furuse Y, Jindai K
    Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020.
    Int J Infect Dis. 2020 May 31. pii: S1201-9712(20)30395.
    PubMed     Abstract available


  323. ALCOBA-FLOREZ J, Gonzalez-Montelongo R, Inigo-Campos A, de Artola DG, et al
    Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.
    Int J Infect Dis. 2020 May 31. pii: S1201-9712(20)30406.
    PubMed     Abstract available


  324. KANG CK, Han GC, Kim M, Kim G, et al
    Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity.
    Int J Infect Dis. 2020 May 31. pii: S1201-9712(20)30413.
    PubMed     Abstract available


  325. DE MEYER S, Bojkova D, Cinatl J, Van Damme E, et al
    Lack of Antiviral Activity of Darunavir against SARS-CoV-2.
    Int J Infect Dis. 2020 May 29. pii: S1201-9712(20)30392.
    PubMed     Abstract available


  326. MA S, Lai X, Chen Z, Tu S, et al
    Clinical Characteristics of Critically Ill Patients Co-infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30375.
    PubMed     Abstract available


  327. MIDDELBURG RA, Rosendaal FR
    COVID-19: how to make between-country comparisons.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30373.
    PubMed     Abstract available


  328. LIN YC, Cheng CY, Cheng-Pin C, Cheng SH, et al
    A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30377.
    PubMed     Abstract available


  329. RIVAS AL, Febles JL, Smith SD, Hoogesteijn AL, et al
    Early network properties of the COVID-19 pandemic - the Chinese scenario.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30356.
    PubMed     Abstract available


  330. JANG S, Rhee JY
    Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30379.
    PubMed     Abstract available


  331. WANG Q, Hu Z
    Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30372.
    PubMed     Abstract available


  332. WU D, Lu J, Cao L, Ma X, et al
    Positive effects of COVID-19 control measures on pneumonia prevention.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30376.
    PubMed    


  333. OLUM R, Bongomin F
    Uganda's First 100 COVID-19 Cases: Trends and Lessons.
    Int J Infect Dis. 2020 May 25. pii: S1201-9712(20)30380.
    PubMed    


  334. EAASWARKHANTH M, Madhoun AA, Al-Mulla F
    Could the D614 G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?
    Int J Infect Dis. 2020 May 25. pii: S1201-9712(20)30378.
    PubMed     Abstract available


  335. ANDREA V, Gianluca F, Rodolfo P, Paolo T, et al
    Unheralded Lower Limb Threatening Ischemia in a COVID-19 Patient.
    Int J Infect Dis. 2020 May 21. pii: S1201-9712(20)30367.
    PubMed     Abstract available


  336. BEARMAN G, Pryor R, Vokes R, Cooper K, et al
    Reflections on the COVID-19 Pandemic in the USA: Will We Better Prepared Next Time?
    Int J Infect Dis. 2020 May 20. pii: S1201-9712(20)30366.
    PubMed     Abstract available


  337. ZENG F, Huang Y, Guo Y, Yin M, et al
    Association of inflammatory markers with the severity of COVID-19: a meta-analysis.
    Int J Infect Dis. 2020 May 18. pii: S1201-9712(20)30362.
    PubMed     Abstract available


  338. MARAIS BJ, Sorrell TC
    Pathways to COVID-19 'community protection'.
    Int J Infect Dis. 2020 May 18. pii: S1201-9712(20)30365.
    PubMed    


  339. OVERHOFF D, Walter T, Gruettner J, Janssen S, et al
    Acute pulmonary embolism mimicking COVID - 19 pneumonia.
    Int J Infect Dis. 2020 May 18. pii: S1201-9712(20)30360.
    PubMed    


  340. ZUMLA A, Wang FS, Ippolito G, Petrosillo N, et al
    Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - achieving global consensus and visibility for cellular host-directed therapies.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30347.
    PubMed     Abstract available


  341. MACHIDA M, Nakamura I, Saito R, Nakaya T, et al
    Changes in implementation of personal protective measures by ordinary Japanese citizens: A longitudinal study from the early phase to the community transmission phase of the COVID-19 outbreak.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30346.
    PubMed     Abstract available


  342. QI L, Yang Y, Jiang D, Tu C, et al
    Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China: A retrospective cohort study.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30352.
    PubMed     Abstract available


  343. HOEFER A, Pampaka D, Wagner ER, Herrera AA, et al
    Management of a COVID-19 outbreak in a Hotel in Tenerife, Spain.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30354.
    PubMed     Abstract available


  344. XIA Y, Hong H, Feng Y, Liu M, et al
    Dynamics of antibodies to SARS-CoV-2 in a case with SARS-CoV-2 infection.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30349.
    PubMed    


  345. ZHAO N, Liu Y, Smaragiassi A, Bernatsky S, et al
    Tracking the origin of early COVID-19 cases in Canada.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30353.
    PubMed     Abstract available


  346. HU B, Qiu J, Chen H, Tao V, et al
    First, second and potential third generation spreads of the COVID-19 epidemic in mainland China: an early exploratory study incorporating location-based service data of mobile devices.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30355.
    PubMed     Abstract available


  347. RAINISCH G, Undurraga EA, Chowell G
    A dynamic modeling tool for estimating healthcare demand from the COVID19 epidemic and evaluating population-wide interventions.
    Int J Infect Dis. 2020 May 16. pii: S1201-9712(20)30350.
    PubMed     Abstract available


  348. FRANZETTI M, Pozzetti U, Carugati M, Pandolfo A, et al
    Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report.
    Int J Infect Dis. 2020 May 15. pii: S1201-9712(20)30357.
    PubMed     Abstract available


  349. CHONG KC, Cheng W, Zhao S, Ling F, et al
    Monitoring disease transmissibility of 2019 novel coronavirus disease in Zhejiang, China.
    Int J Infect Dis. 2020;96:128-130.
    PubMed     Abstract available


  350. CALDERARO A, Arcangeletti MC, De Conto F, Buttrini M, et al
    SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian seven-week-old suckling baby.
    Int J Infect Dis. 2020 May 14. pii: S1201-9712(20)30342.
    PubMed     Abstract available


  351. LEE H, Park SJ, Lee GR, Kim JE, et al
    The Relationship between the COVID-19 Prevalence Trend and Transportation Trend in South Korea.
    Int J Infect Dis. 2020 May 14. pii: S1201-9712(20)30339.
    PubMed     Abstract available


  352. KIM S, Jeong YD, Byun JH, Cho G, et al
    Evaluation of COVID-19 epidemic outbreak caused by temporal contact-increase in South Korea.
    Int J Infect Dis. 2020 May 14. pii: S1201-9712(20)30343.
    PubMed     Abstract available


  353. WORKMAN J
    Proportion of COVID-19 Cases that Are Asymptomatic in South Korea: Comment on Nishiura et al.
    Int J Infect Dis. 2020 May 14. pii: S1201-9712(20)30344.
    PubMed    


  354. KOWALSKA JD, Skrzat-Klapaczynska A, Bursa D, Balayan T, et al
    HIV care in times of the COVID-19 crisis - where are we now in Central and Eastern Europe?
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30319.
    PubMed     Abstract available


  355. MBOERA LEG, Akipede GO, Banerjee A, Cuevas LE, et al
    Mitigating lockdown challenges in the response to COVID-19 in Sub-Saharan Africa.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30325.
    PubMed    


  356. FAN H, Zhang L, Huang B, Zhu M, et al
    Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30331.
    PubMed     Abstract available


  357. FILOCAMO G, Mangioni D, Tagliabue P, Aliberti S, et al
    Use of anakinra in severe COVID-19: a case report.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30333.
    PubMed     Abstract available


  358. ZHOU R, Li F, Chen F, Liu H, et al
    Viral dynamics in asymptomatic patients with COVID-19.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30337.
    PubMed     Abstract available


  359. GUALANO G, Musso M, Mosti S, Mencarini P, et al
    Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30334.
    PubMed     Abstract available


  360. SOARES F, Yamashita GH
    On the crucial role of multilingual biomedical databases on epidemic events (SARS-CoV-2 analysis).
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30330.
    PubMed    


  361. CHINTALAPUDI N, Battineni G, Sagaro GG, Amenta F, et al
    COVID-19 outbreak reproduction number estimations and forecasting in Marche, Italy.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30336.
    PubMed     Abstract available


  362. BELDOMENICO PM
    Do superspreaders generate new superspreaders? a hypothesis to explain the propagation pattern of COVID-19.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30332.
    PubMed     Abstract available


  363. RAN J, Zhao S, Zhuang Z, Chong MK, et al
    Quantifying the improvement in confirmation efficiency of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early phase of outbreak in Hong Kong in 2020.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30321.
    PubMed     Abstract available


  364. BORGHESI A, Zigliani A, Golemi S, Carapella N, et al
    Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: A study of 302 patients from Italy.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30328.
    PubMed     Abstract available


  365. PUTRA BE, Adiarto S, Dewayanti SR, Juzar DA, et al
    Viral Exanthem with "Pin and Needles Sensation" on Extremities of COVID-19 Patient.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30327.
    PubMed     Abstract available


  366. SO MKP, Tiwari A, Chu AMY, Tsang JTY, et al
    Visualising COVID-19 Pandemic Risk through Network Connectedness.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30317.
    PubMed     Abstract available


  367. SHANG Y, Xu C, Jiang F, Huang R, et al
    Clinical characteristics and changes of chest CT features in 307 patients with common COVID-19 pneumonia infected SARS-CoV-2: A multicenter study in Jiangsu, China.
    Int J Infect Dis. 2020;96:157-162.
    PubMed     Abstract available


  368. SHEN M, Peng Z, Guo Y, Rong L, et al
    Assessing the Effects of Metropolitan-Wide Quarantine on the Spread of COVID-19 in Public Space and Households.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30326.
    PubMed     Abstract available


  369. ABBARA A, Rayes D, Fahham O, Alhiraki OA, et al
    Coronavirus 2019 and health systems affected by protracted conflict: The case of Syria.
    Int J Infect Dis. 2020;96:192-195.
    PubMed     Abstract available


  370. GALLINA P, Ricci M
    Covid-19 health crisis management in Europe: decisive assessment is needed now.
    Int J Infect Dis. 2020 May 7. pii: S1201-9712(20)30316.
    PubMed    


  371. QUADRI SA
    COVID-19 and religious congregations: Implications for spread of novel pathogens.
    Int J Infect Dis. 2020;96:219-221.
    PubMed     Abstract available


  372. LI Y, Wang J, Wang C, Yang Q, et al
    Characteristics of respiratory virus infection during the outbreak of 2019 novel coronavirus in Beijing.
    Int J Infect Dis. 2020 May 7. pii: S1201-9712(20)30314.
    PubMed     Abstract available


  373. ZHOU MY, Xie XL, Peng YG, Wu MJ, et al
    From SARS to COVID-19: What we have learned about children infected with COVID-19.
    Int J Infect Dis. 2020 May 7. pii: S1201-9712(20)30309.
    PubMed     Abstract available


  374. GIRAUD-GATINEAU A, Colson P, Jimeno MT, Zandotti C, et al
    Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year in Southeastern France.
    Int J Infect Dis. 2020;96:154-156.
    PubMed     Abstract available


  375. SHETE A
    Urgent need for evaluating agonists of Angiotensin-(1-7)/ Mas receptor axis for treatment of patients with COVID-19.
    Int J Infect Dis. 2020 May 7. pii: S1201-9712(20)30307.
    PubMed     Abstract available


  376. OMORI R, Mizumoto K, Nishiura H
    Ascertainment rate of novel coronavirus disease (COVID-19) in Japan.
    Int J Infect Dis. 2020 May 7. pii: S1201-9712(20)30292.
    PubMed     Abstract available


  377. KIM SE, Jeong HS, Yu Y, Shin SU, et al
    Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients.
    Int J Infect Dis. 2020 May 3. pii: S1201-9712(20)30299.
    PubMed     Abstract available


  378. ZHAO Q, Meng M, Kumar R, Wu Y, et al
    Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis.
    Int J Infect Dis. 2020 May 3. pii: S1201-9712(20)30301.
    PubMed     Abstract available


  379. SHEN CY
    A logistic growth model for COVID-19 proliferation: experiences from China and international implications in infectious diseases.
    Int J Infect Dis. 2020 May 3. pii: S1201-9712(20)30303.
    PubMed     Abstract available


  380. LUO Y, Yuan X, Xue Y, Mao L, et al
    Using the diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus.
    Int J Infect Dis. 2020 May 1. pii: S1201-9712(20)30295.
    PubMed     Abstract available


  381. WANG X, Tan L, Wang X, Liu W, et al
    Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously.
    Int J Infect Dis. 2020;94:107-109.
    PubMed     Abstract available


  382. HE D, Zhao S, Lin Q, Zhuang Z, et al
    The relative transmissibility of asymptomatic COVID-19 infections among close contacts.
    Int J Infect Dis. 2020;94:145-147.
    PubMed     Abstract available


  383. WANG J, Feng H, Zhang S, Ni Z, et al
    SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital.
    Int J Infect Dis. 2020;94:103-106.
    PubMed     Abstract available


  384. MACHIDA M, Nakamura I, Saito R, Nakaya T, et al
    Adoption of personal protective measures by ordinary citizens during the COVID-19 outbreak in Japan.
    Int J Infect Dis. 2020;94:139-144.
    PubMed     Abstract available


  385. YE F, Xu S, Rong Z, Xu R, et al
    Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster.
    Int J Infect Dis. 2020;94:133-138.
    PubMed     Abstract available


  386. XIE M, Chen Q
    Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV.
    Int J Infect Dis. 2020;94:119-124.
    PubMed     Abstract available


    April 2020
  387. AHMADI A, Kheiril S, Mohammadian-Hafshejani A, Raeisi H, et al
    The accuracy of "Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A modelling analysis based on overseas cases and air travel data".
    Int J Infect Dis. 2020 Apr 30. pii: S1201-9712(20)30287.
    PubMed    


  388. GU Y, Lu J, Yang Z
    Pilgrimage and COVID-19: the risk among returnees from Muslim countries.
    Int J Infect Dis. 2020 Apr 30. pii: S1201-9712(20)30282.
    PubMed     Abstract available


  389. OCHOA YC, Sanchez DER, Penaloza M, Motta HFC, et al
    Effective Reproductive Number estimation for initial stage of COVID-19 pandemic in Latin American Countries.
    Int J Infect Dis. 2020 Apr 30. pii: S1201-9712(20)30285.
    PubMed     Abstract available


  390. ZHUANG Z, Zhao S, Lin Q, Cao P, et al
    Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A reply to Sharifi.
    Int J Infect Dis. 2020 Apr 30. pii: S1201-9712(20)30289.
    PubMed    


  391. UJIIE M, Tsuzuki S, Ohmagari N
    Effect of temperature on the infectivity of COVID-19.
    Int J Infect Dis. 2020 Apr 30. pii: S1201-9712(20)30284.
    PubMed     Abstract available


  392. MUBARAK N
    Corona and Clergy: The missing link for an effective social distancing in Pakistan. Time for some unpopular decisions.
    Int J Infect Dis. 2020 Apr 30. pii: S1201-9712(20)30283.
    PubMed    


  393. PETERSEN E, Wasserman S, Lee SS, Go U, et al
    COVID-19-We urgently need to start developing an exit strategy.
    Int J Infect Dis. 2020 Apr 28. pii: S1201-9712(20)30251.
    PubMed     Abstract available


  394. QIANCHENG X, Jian S, Lingling P, Lei H, et al
    Coronavirus disease 2019 in pregnancy.
    Int J Infect Dis. 2020 Apr 27. pii: S1201-9712(20)30280.
    PubMed     Abstract available


  395. OHIA C, Bakarey AS, Ahmad T
    COVID-19 and Nigeria: Putting the realities in context.
    Int J Infect Dis. 2020 Apr 27. pii: S1201-9712(20)30281.
    PubMed     Abstract available


  396. WANG X, Zhou Y, Jiang N, Zhou Q, et al
    Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved.
    Int J Infect Dis. 2020 Apr 27. pii: S1201-9712(20)30279.
    PubMed     Abstract available


  397. CHANDA-KAPATA P, Kapata N, Zumla A
    COVID-19 and malaria: A symptom screening challenge for malaria endemic countries.
    Int J Infect Dis. 2020;94:151-153.
    PubMed    


  398. VELAVAN TP, Meyer CG
    Mild versus severe COVID-19: laboratory markers.
    Int J Infect Dis. 2020 Apr 25. pii: S1201-9712(20)30277.
    PubMed     Abstract available


  399. MI YN, Huang TT, Zhang JX, Qin Q, et al
    Estimating instant case fatality rate of COVID-19 in China.
    Int J Infect Dis. 2020 Apr 24. pii: S1201-9712(20)30271.
    PubMed     Abstract available


  400. SCIALPI M, Scialp S, Piscioli I, Scalera G, et al
    Pulmonary thromboembolism in criticall ill COVID-19 patients.
    Int J Infect Dis. 2020 Apr 24. pii: S1201-9712(20)30272.
    PubMed    


  401. WANG P, Lu JA, Jin Y, Zhu M, et al
    Statistical and network analysis of 1212 COVID-19 patients in Henan, China.
    Int J Infect Dis. 2020 Apr 24. pii: S1201-9712(20)30267.
    PubMed     Abstract available


  402. AMIRIAN ES
    Potential Fecal Transmission of SARS-CoV-2: Current Evidence and Implications for Public Health.
    Int J Infect Dis. 2020 Apr 23. pii: S1201-9712(20)30273.
    PubMed     Abstract available


  403. WANG M, Luo L, Bu H, Xia H, et al
    Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count.
    Int J Infect Dis. 2020 Apr 23. pii: S1201-9712(20)30276.
    PubMed     Abstract available


  404. CAO D, Yin H, Chen J, Tang F, et al
    Clinical analysis of ten pregnant women with COVID-19 in Wuhan, China: A retrospective study.
    Int J Infect Dis. 2020 Apr 23. pii: S1201-9712(20)30263.
    PubMed     Abstract available


  405. DOUGLAS D, Douglas R
    Addressing the corona virus outbreak: will a novel filtered eye mask help?
    Int J Infect Dis. 2020 Apr 22. pii: S1201-9712(20)30255.
    PubMed     Abstract available


  406. ZHU Z, Cai T, Fan L, Lou K, et al
    Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019.
    Int J Infect Dis. 2020 Apr 22. pii: S1201-9712(20)30257.
    PubMed     Abstract available


  407. HU Z, Cui Q, Han J, Wang X, et al
    Evaluation and prediction of the COVID-19 variations at different input population and quarantine strategies, a case study in Guangdong province, China.
    Int J Infect Dis. 2020 Apr 22. pii: S1201-9712(20)30226.
    PubMed     Abstract available


  408. HINJOY S, RoyceTsukayama, Chuxnum T, Masunglong W, et al
    A self-assessment of the Thai Department of Disease Control's communication for international response at early phase to the COVID-19.
    Int J Infect Dis. 2020 Apr 22. pii: S1201-9712(20)30258.
    PubMed     Abstract available


  409. ZHUANG Z, Zhao S, Lin Q, Cao P, et al
    Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020.
    Int J Infect Dis. 2020 Apr 22. pii: S1201-9712(20)30259.
    PubMed     Abstract available


  410. DU W, Han S, Li Q, Zhang Z, et al
    Epidemic update of COVID-19 in Hubei Province compared with other regions in China.
    Int J Infect Dis. 2020 Apr 20. pii: S1201-9712(20)30246.
    PubMed     Abstract available


  411. OMORI R, Mizumoto K, Chowell G
    Changes in testing rates could mask the novel coronavirus disease (COVID-19) growth rate.
    Int J Infect Dis. 2020;94:116-118.
    PubMed     Abstract available


  412. EFFENBERGER M, Kronbichler A, Shin JI, Mayer G, et al
    Association of the COVID-19 pandemic with Internet Search Volumes: A Google Trends(TM) Analysis.
    Int J Infect Dis. 2020 Apr 16. pii: S1201-9712(20)30249.
    PubMed     Abstract available


  413. PETERSEN E, McCloskey B, Hui DS, Kock R, et al
    COVID-19 travel restrictions and the International Health Regulations - call for an open debate on easing of travel restrictions.
    Int J Infect Dis. 2020 Apr 16. pii: S1201-9712(20)30245.
    PubMed    


  414. SEE KC, Liew SM, Ng DCE, Chew EL, et al
    COVID-19: Four Paediatric Cases in Malaysia.
    Int J Infect Dis. 2020 Apr 15. pii: S1201-9712(20)30181.
    PubMed     Abstract available


  415. WANG R, Pan M, Zhang X, Fan X, et al
    Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China.
    Int J Infect Dis. 2020 Apr 11. pii: S1201-9712(20)30203.
    PubMed     Abstract available


  416. KENYON C
    The serostatus approach to fighting COVID-19.
    Int J Infect Dis. 2020 Apr 7. pii: S1201-9712(20)30213.
    PubMed    


  417. DAI H, Zhang X, Xia J, Zhang T, et al
    High-resolution Chest CT Features and Clinical Characteristics of Patients Infected with COVID-19 in Jiangsu, China.
    Int J Infect Dis. 2020 Apr 6. pii: S1201-9712(20)30218.
    PubMed     Abstract available


  418. LI X, Wang L, Yan S, Yang F, et al
    Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China.
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30186.
    PubMed     Abstract available


  419. JIN Y, Wang M, Zuo Z, Fan C, et al
    Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019.
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30198.
    PubMed     Abstract available


  420. MAO ZQ, Wan R, He LY, Hu YC, et al
    The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30173.
    PubMed     Abstract available


  421. HONG X, Xiong J, Feng Z, Shi Y, et al
    Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30191.
    PubMed     Abstract available


  422. MORIGUCHI T, Harii N, Goto J, Harada D, et al
    A first Case of Meningitis/Encephalitis associated with SARS-Coronavirus-2.
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30195.
    PubMed     Abstract available


  423. LAW S, Leung AW, Xu C
    Severe Acute Respiratory Syndrome (SARS) and Coronavirus disease-2019 (COVID-19): From Causes to Preventions in Hong Kong.
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30192.
    PubMed     Abstract available


  424. KANG D, Choi H, Kim JH, Choi J, et al
    Spatial epidemic dynamics of the COVID-19 outbreak in China.
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30209.
    PubMed     Abstract available


    March 2020
  425. YUAN J, Li M, Lv G, Lu ZK, et al
    Monitoring Transmissibility and Mortality of COVID-19 in Europe.
    Int J Infect Dis. 2020 Mar 28. pii: S1201-9712(20)30182.
    PubMed     Abstract available


  426. ZHENG C, Wang J, Guo H, Lu Z, et al
    Risk-adapted Treatment Strategy For COVID-19 Patients.
    Int J Infect Dis. 2020 Mar 27. pii: S1201-9712(20)30179.
    PubMed     Abstract available


  427. ZHANG X, Cai H, Hu J, Lian J, et al
    Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings.
    Int J Infect Dis. 2020 Mar 20. pii: S1201-9712(20)30172.
    PubMed     Abstract available


  428. ZHANG JF, Yan K, Ye HH, Lin J, et al
    SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge.
    Int J Infect Dis. 2020 Mar 18. pii: S1201-9712(20)30126.
    PubMed     Abstract available


  429. SHIM E, Tariq A, Choi W, Lee Y, et al
    Transmission potential and severity of COVID-19 in South Korea.
    Int J Infect Dis. 2020 Mar 17. pii: S1201-9712(20)30150.
    PubMed     Abstract available


  430. LI P, Fu JB, Li KF, Chen Y, et al
    Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster.
    Int J Infect Dis. 2020 Mar 16. pii: S1201-9712(20)30146.
    PubMed     Abstract available


  431. MENDELSON M
    Could enhanced influenza and pneumococcal vaccination programs help limit the potential damage from SARS-CoV-2 to fragile health systems of southern hemisphere countries this winter?
    Int J Infect Dis. 2020 Mar 16. pii: S1201-9712(20)30149.
    PubMed    


  432. XU T, Chen C, Zhu Z, Cui M, et al
    Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19.
    Int J Infect Dis. 2020 Mar 13. pii: S1201-9712(20)30141.
    PubMed     Abstract available


  433. NISHIURA H, Kobayashi T, Suzuki A, Jung SM, et al
    Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).
    Int J Infect Dis. 2020 Mar 13. pii: S1201-9712(20)30139.
    PubMed    


  434. LIU F, Xu A, Zhang Y, Xuan W, et al
    Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression.
    Int J Infect Dis. 2020 Mar 12. pii: S1201-9712(20)30132.
    PubMed     Abstract available


  435. YANG J, Zheng Y, Gou X, Pu K, et al
    Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis.
    Int J Infect Dis. 2020 Mar 12. pii: S1201-9712(20)30136.
    PubMed     Abstract available


  436. HUSNAYAIN A, Fuad A, Su EC
    Applications of google search trends for risk communication in infectious disease management: A case study of COVID-19 outbreak in Taiwan.
    Int J Infect Dis. 2020 Mar 12. pii: S1201-9712(20)30140.
    PubMed     Abstract available


  437. WU D, Wu T, Liu Q, Yang Z, et al
    The SARS-CoV-2 outbreak: what we know.
    Int J Infect Dis. 2020 Mar 11. pii: S1201-9712(20)30123.
    PubMed     Abstract available


  438. ZHUANG Z, Zhao S, Lin Q, Cao P, et al
    Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A modelling analysis based on overseas cases and air travel data.
    Int J Infect Dis. 2020 Mar 11. pii: S1201-9712(20)30138.
    PubMed     Abstract available


  439. TANG B, Xia F, Tang S, Bragazzi NL, et al
    The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China.
    Int J Infect Dis. 2020 Mar 11. pii: S1201-9712(20)30137.
    PubMed     Abstract available


  440. CHEN D, Xu W, Lei Z, Huang Z, et al
    Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report.
    Int J Infect Dis. 2020 Mar 5. pii: S1201-9712(20)30122.
    PubMed     Abstract available


  441. NISHIURA H, Linton NM, Akhmetzhanov AR
    Serial interval of novel coronavirus (COVID-19) infections.
    Int J Infect Dis. 2020 Mar 4. pii: S1201-9712(20)30119.
    PubMed     Abstract available


  442. LIN Q, Zhao S, Gao D, Lou Y, et al
    A conceptual model for the outbreak of Coronavirus disease 2019 (COVID-19) in Wuhan, China with individual reaction and governmental action.
    Int J Infect Dis. 2020 Mar 4. pii: S1201-9712(20)30117.
    PubMed     Abstract available


  443. PETERSEN E, Hui D, Hamer DH, Blumberg L, et al
    Li Wenliang, a face to the frontline healthcare worker? The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak.
    Int J Infect Dis. 2020 Mar 3. pii: S1201-9712(20)30111.
    PubMed    


    February 2020
  444. KAPATA N, Ihekweazu C, Ntoumi F, Tajudeen R, et al
    Is the Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic? - lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future.
    Int J Infect Dis. 2020 Feb 28. pii: S1201-9712(20)30107.
    PubMed    


  445. XIE C, Jiang L, Huang G, Pu H, et al
    Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests.
    Int J Infect Dis. 2020 Feb 27. pii: S1201-9712(20)30108.
    PubMed     Abstract available


  446. ALBARELLO F, Pianura E, Di Stefano F, Cristofaro M, et al
    2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation.
    Int J Infect Dis. 2020 Feb 26. pii: S1201-9712(20)30101.
    PubMed     Abstract available


  447. ZHANG S, Diao M, Yu W, Pei L, et al
    Estimation of the reproductive number of Novel Coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis.
    Int J Infect Dis. 2020 Feb 22. pii: S1201-9712(20)30091.
    PubMed     Abstract available


  448. ZHAO S, Lin Q, Ran J, Musa SS, et al
    The basic reproduction number of novel coronavirus (2019-nCoV) estimation based on exponential growth in the early outbreak in China from 2019 to 2020: A reply to Dhungana.
    Int J Infect Dis. 2020 Feb 20. pii: S1201-9712(20)30083.
    PubMed    


  449. DHUNGANA HN
    Comments on "Preliminary estimation of the basic reproduction number of novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven Analysis in the early phase of the outbreak".
    Int J Infect Dis. 2020 Feb 20. pii: S1201-9712(20)30082.
    PubMed    


  450. HUI DS, I Azhar E, Madani TA, Ntoumi F, et al
    The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.
    Int J Infect Dis. 2020;91:264-266.
    PubMed    


    January 2020
  451. ZHAO S, Lin Q, Ran J, Musa SS, et al
    Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak.
    Int J Infect Dis. 2020 Jan 30. pii: S1201-9712(20)30053.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO COVID-19 is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: